Company / R&D per Share
Immunocore Holdings plc R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$5.49
FY2025
5-year range
$2.23 / $5.49
FY2021-FY2025
Trend
+22.9%
vs FY2024
Sector context
#30 of 208
Health Care
What the data says
Immunocore Holdings plc's r&d per share of $5.49 is higher than 86% of companies in the Health Care sector (FY2025). R&D per Share has increased for 3 consecutive years, from $2.23 in FY2022 to $5.49 in FY2025.
Based on SEC 10-K filings.
5.49 in FY2025 with a 3-year CAGR of +35.0%. Top quartile in the Health Care sector.
Improved from $3.40 to $5.49 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +35.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 208This company $5.49 Sector average $28.82
▼
-80.9% below sector average
Key checks
Key Insights
- Immunocore Holdings plc's r&d per share has grown for 3 consecutive years.
- In FY2025, r&d per share increased 22.9% year-over-year.
- Ranks #30 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.49 | +22.9% |
| FY2024 | $4.47 | +31.4% |
| FY2023 | $3.40 | +52.5% |
| FY2022 | $2.23 | -5.5% |
| FY2021 | $2.36 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026